Immunotherapy has changed the standard of care for multiple deadly cancers, including
lung, head and neck, gastric, and some colorectal cancers. However, single-agent …

DNA vaccination represents a smart and promising approach to cancer immunotherapy.
DNA vaccines for cancer immunotherapy are designed to deliver one or several genes …

Abstract Background Dendritic cells (DCs) enhance the quality of anti-tumor immune
response in patients with cancer. Thus, we posit that DC-based immunotherapy, in …

Purpose: Preclinical studies demonstrated that a DNA vaccine (pTVG-AR, MVI-118)
encoding the androgen receptor ligand-binding domain (AR LBD) augmented antigen …

The ultimate goal of therapeutic vaccines is to activate and exploit the patient's own immune
system to vigorously and dynamically seek and eradicate established malignant or virally …

Pancreatic adenocarcinoma is the fourth leading cause of cancer death with an overall 5-
year survival of less than 5%. As there is ample evidence that pancreatic adenocarcinomas …

US7691393B2 - Listeria attenuated for entry into non-phagocytic cells, vaccines comprising
the Listeria, and methods of use thereof - Google Patents US7691393B2 - Listeria …

A variety of antigens that display a highly tissue-specific expression pattern have recently
found to be also expressed in medullary thymic epithelial cells (mTEC). This unique feature …

2005-06-20 Assigned to CERUS CORPORATION reassignment CERUS CORPORATION
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …

The androgen receptor (AR) plays an essential role in the development and progression of
prostate cancer. However, while it has long been the primary molecular target of metastatic …